Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Frank Brosius
Professor, Medicine | Member of the Graduate Faculty
Medicine
Overview
Research
More
Collaboration
(19)
Nathan Cherrington
Mutual work: 1 Proposal
Collaboration Details
Jason Wertheim
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Jean-Philippe Galons
Mutual work: 1 Proposal﹒1 Grant
Collaboration Details
Marvin Slepian
Mutual work: 2 Proposals﹒1 Grant
Collaboration Details
Erika Bracamonte
Mutual work: 2 Proposals﹒1 Grant
Collaboration Details
Page 1 of 4
Previous page
Next page
Grants
(8)
Renal Denervation to Treat Polycystic Kidney Disease: Mechanisms and Mediators
Active
·
2023
·
$90K / $600.2K
·
External
Co-Investigator (COI)
renal denervation,
polycystic kidney disease,
mechanisms,
mediators,
treatment
REMODEL - Renal Mode Of Action Of Semaglutide In Patients With Type 2 Diabetes And Chronic Kidney Disease
Active
·
2023
·
$805.2K / $161K
·
External
Principal Investigator (PI)
diabetes,
kidney disease,
semaglutide,
renal function,
treatment
Geographic and Environmental Health Equity in Kidney Precision Medicine
Active
·
2022
·
$274.5K / $361.2K
·
External
Principal Investigator (PI)
geographic health,
environmental health,
kidney precision medicine,
health equity,
precision medicine
Arizona Technology Development and Clinical Education Program for Students in Kidney Health (ADVANCE Kidney Health)
Active
·
2021
·
$84.2K / $421.2K
·
External
Multiple Principal Investigator (MPI)
technology,
clinical education,
kidney health,
development,
students
Transformative Research In DiabEtic NephropaThy (TRIDENT)
Active
·
2019
·
$168.4K
·
External
Principal Investigator (PI)
diabetic nephropathy,
transformative research,
kidney disease,
diabetes,
medical intervention
Page 1 of 2
Previous page
Next page
Publications
(288)
Recent
The deacylase sirtuin 5 reduces malonylation in nonmitochondrial metabolic pathways in diabetic kidney disease
2023
sirtuin 5,
malonylation,
diabetic kidney disease,
metabolic pathways,
deacylase
Cannabinoid Signaling in the Diabetic Proximal Tubule: Of Mice and Men
2023
cannabinoid signaling,
diabetic nephropathy,
renal physiology,
diabetes mellitus,
endocannabinoid system
Outcomes with finerenone in participants with stage 4 CKD and type 2 diabetes: a FIDELITY subgrouanalysis
2023
chronic kidney disease,
diabetes,
clinical trial,
cardiovascular outcomes,
drug therapy
Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
2023
diabetes treatment,
drug effects,
meta-analysis,
randomized trials,
health outcomes
WCN23-0761 SGLT2 INHIBITOR TREATMENT MAY ENHANCE KIDNEY OXYGENATION AND ATTENUATE HIF1A EXPRESSION IN YOUNG PERSONS WITH TYPE 2 DIABETES
2023
diabetes,
sglt2 inhibitor,
kidney health,
oxygenation,
hif1a expression
SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes
2023
diabetes,
kidney health,
metabolism,
youth health,
mtorc1 pathway
WCN23-0472 UNDERSTANDING THE MECHANISM OF SGLT2 INHIBITOR IN YOUNG PERSONS WITH TYPE 2 DIABETES USING SINGLE-CELL RNA-SEQ DATA
2023
diabetes,
sglt2 inhibitor,
single-cell rna-seq,
mechanism,
young persons
Moving from evidence to implementation of breakthrough therapies for diabetic kidney disease
2022
diabetic kidney disease,
breakthrough therapies,
implementation,
evidence-based intervention,
diabetes management
KDOQI US commentary on the KDIGO 2020 clinical practice guideline for diabetes management in CKD
2022
diabetes management,
chronic kidney disease,
clinical practice guideline,
kdoqi commentary
SGLT2 inhibition mitigates perturbations in nephron segment-specific metabolic transcripts and mTOR pathway activity in kidneys of young persons with type 2 diabetes
2022
diabetes,
kidney function,
metabolism,
sglt2 inhibition,
mtor pathway